期刊文献+

帕金森病LRRK2基因单核苷酸rs34778348:G>A多态性分析 被引量:2

Single Nucleotide Polymorphism Analysis for LRRK2 rs34778348:G>A of Parkinson′s Disease
下载PDF
导出
摘要 基因的单核苷酸多态性(single nucleotide polymorphism,SNP)是导致帕金森病(Parkinson′s disease)发生的遗传因素之一,但受不同种族和地域的影响.通过联合使用引物重叠PCR定点突变,限制性长度多态性分析(restriction fragment length polymorphism,RFLP)筛查了帕金森病的重要致病基因Leucine-Rich Repeat kinase 2(LRRK2)的突变体:rs34778348:G>A(G2385R);用毛细管电泳(capillary electrophoresis,CE)技术进行验证.在237个散发性帕金森病人和190个对照者中虽然未发现rs34778348:G>A的纯合子突变,但存在rs34778348:G>A的杂合子突变,并且统计分析显示病例组与对照组rs34778348:G>A的等位基因频率(p=0.010)和基因型频率(p=0.001)差异显著.显示筛查到rs34778348:G>A可能是中国散发帕金森病易感性的风险因子.该方法有助于促进帕金森病分子诊断的临床普及. Parkinson's disease (PD) is a degenerative disorder of central nerve system (CNS),genetically attributed by known mutations of leucine-rich repeat kinase (LRRK2),alpha-synuclein (SNAC),PTEN-induced putative kinase 1 (PINK1)etc.Single nucleotide polymorphism (SNP),rs34778348:G〉A (G2385R) in LRRK2 is the most common known cause of about 5 % familiar and 3 % sporadic PD in Europe.In this study,site-specific mutation primer overlapping PCR,restriction fragment length polymorphism (RFLP) and capillary electrophoresis (CE) were applied to systematically analyze the risk factor,rs34778348:G〉A,from 237 sporadic PD patients and 190 normal Chinese.24 heterozygous SNP carriers out of 237 (10.1%) PD patients and 4 heterozygous SNP carriers out of 190 (2.1%) controls were significantly detected with p value of 0.001 and 0.010 of genotype and allele frequency,respectively.It implies that rs34778348:G〉A in LRRK2 is a potential risk factor of PD in Chinese population.Furthermore,we established the positive control of rs34778348:G〉A and mutation diagnostic standard operation procedures (SOPs) to promote the commercialization of molecular diagnosis in PD.
出处 《厦门大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第6期860-865,共6页 Journal of Xiamen University:Natural Science
基金 福建省科技计划项目(2012D062)
关键词 帕金森病 LRRK2 rs34778348 G>A 限制性长度多态性分析(RFLP) Parkinson's disease LRRK2 rs34778348 .. G〉A restriction fragment length polymorphism(RFLP)
  • 相关文献

参考文献23

  • 1Zhang Z X,Roman G C,Hong Z. Parkinson's disease in China:prevalence in Beijing,Xi'an,and Shanghai[J].The Lancet,2005,(9459):595-597.
  • 2Fahn S. Description of Parkinson's disease as a clinical syndrome[J].Annals of the New York Academy of Sciences,2003.1-14.
  • 3Forno L S. Neuropathology of Parkinson's disease[J].Journal of Neuropathology and Experimental Neurology,1996,(03):259-272.
  • 4Dauer W,Przedborski S. Parkinson's disease:mechanisms and models[J].Neuron,2003,(06):889-909.
  • 5Dawson T M,Dawson V L. Molecular pathways of neurodegeneration in Parkinson's disease[J].Science,2003,(5646):819-822.doi:10.1126/science.1087753.
  • 6Cookson M R. The biochemistry of Parkinson's disease[J].Annual Review of Biochemistry,2005.29-52.
  • 7Mata I F,Wedemeyer W J,Farrer M J. LRRK2 in Parkinson's disease:protein domains and functional insights[J].Trends in Neurosciences,2006,(05):286-293.
  • 8Tan E K,Shen H,Tan L C. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients[J].Neuroscience Letters,2005,(03):327-329.
  • 9Di Fonzo A,Wu-Chou Y H,Lu C S. A common missense variant in the LRRK2 gene,Gly2385Arg,associated with Parkinson's disease risk in Taiwan[J].Neurogenetics,2006,(03):133-138.
  • 10Farrer M J,Stone J T,Lin C H. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia[J].Parkinsonism and Related Disorders,2007,(02):89-92.

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部